Related references
Note: Only part of the references are listed.Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
Timon A. Bloedjes et al.
CANCERS (2021)
MYC dysregulation in the progression of multiple myeloma
Kristine Misund et al.
LEUKEMIA (2020)
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress
Roberto Ronca et al.
CANCER RESEARCH (2020)
MYC's Fine Line Between B Cell Development and Malignancy
Oriol de Barrios et al.
CELLS (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition
Alba Roca-Portoles et al.
CELL DEATH & DISEASE (2020)
SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation
Yu Xiang et al.
LIFE SCIENCES (2020)
Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers
Zhen Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer
Jae Ho Seo et al.
EBIOMEDICINE (2019)
CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma
Christopher R. Marlein et al.
CANCER RESEARCH (2019)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma
Micol Rava et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Inhibition of autophagy enhances the antitumour activity of tigecycline in multiple myeloma
Ruye Ma et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets
Erik Norberg et al.
CELL DEATH AND DIFFERENTIATION (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma
Xin Zhan et al.
ONCOTARGET (2017)
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
Lynh Nguyen et al.
GENES (2017)
Myc is also the bad guy in myeloma
Elisabet E. Manasanch
LEUKEMIA & LYMPHOMA (2016)
Mitochondria and Cancer
Wei-Xing Zong et al.
MOLECULAR CELL (2016)
Oxidative stress and proteasome inhibitors in multiple myeloma
Brittany C. Lipchick et al.
PHARMACOLOGICAL RESEARCH (2016)
The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
Aleco D'Andrea et al.
ONCOTARGET (2016)
Clinicopathological Implications of Mitochondrial Genome Alterations in Pediatric Acute Myeloid Leukemia
Min-Gu Kang et al.
ANNALS OF LABORATORY MEDICINE (2016)
Mitochondrial DNA copy number variation across human cancers
Ed Reznik et al.
ELIFE (2016)
The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties
Zhijie Xu et al.
FRONTIERS IN PHARMACOLOGY (2016)
AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress
Shrivani Sriskanthadevan et al.
BLOOD (2015)
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Patricia Maiso et al.
CANCER RESEARCH (2015)
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
Brian A. Walker et al.
NATURE COMMUNICATIONS (2015)
NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease
Michelle A. Lawson et al.
PLOS ONE (2015)
The impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy
Naohiro Sekiguchi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
MYC and Mitochondrial Biogenesis
Fionnuala Morrish et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma
Jooeun Bae et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Cytochrome c oxidase dysfunction in oxidative stress
Satish Srinivasan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Marko Skrtic et al.
CANCER CELL (2011)
Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase/Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Jaime M. Ross
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Quantification of mitochondrial DNA copy number: Pre-analytical factors
Antonio L. Andreu et al.
MITOCHONDRION (2009)
ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis-a critical commentary
Jacek Zielonka et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma
Ruben Niesvizky et al.
BLOOD (2008)
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
DR Carrasco et al.
CANCER CELL (2006)
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
F Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Endurance training increases the expression of mitochondrial and nuclear encoded cytochrome c oxidase subunits and heat shock proteins in rat skeletal muscle
TR Samelman et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2000)
Share Paper
